KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,964,000 | -16.3% | 909,083 | -30.9% | 0.29% | +0.3% |
| Q2 2022 | $5,934,000 | -40.1% | 1,315,834 | -2.2% | 0.29% | -27.3% |
| Q1 2022 | $9,912,000 | +20.7% | 1,344,929 | +5.3% | 0.40% | +35.7% |
| Q4 2021 | $8,209,000 | +0.6% | 1,276,634 | -8.9% | 0.29% | -3.3% |
| Q3 2021 | $8,159,000 | -43.9% | 1,401,861 | -0.5% | 0.30% | -41.8% |
| Q2 2021 | $14,545,000 | -11.5% | 1,409,397 | -9.8% | 0.52% | -3.5% |
| Q1 2021 | $16,443,000 | -31.6% | 1,563,044 | +0.7% | 0.54% | -36.6% |
| Q4 2020 | $24,033,000 | +13.1% | 1,552,504 | +6.7% | 0.85% | -1.2% |
| Q3 2020 | $21,246,000 | +47.2% | 1,455,222 | +91.0% | 0.86% | +38.3% |
| Q2 2020 | $14,429,000 | +25.9% | 761,819 | +27.7% | 0.62% | -3.4% |
| Q1 2020 | $11,463,000 | – | 596,745 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |